Abstract
This scientific commentary refers to ‘Cerebral quantitative susceptibility mapping predicts amyloid-β-related cognitive decline’ by Ayton et al., (doi:10.1093/brain/awx137).
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
-
Comment
MeSH terms
-
Alzheimer Disease*
-
Amyloid beta-Peptides
-
Cognitive Dysfunction*
-
Humans
-
Neuropsychological Tests